Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-11

FDA Approved: NAPROXEN — Supplemental Application (Granules India Ltd)

View source ↗

Summary

FDA approved a supplemental application for naproxen sodium granules from Granules India Ltd, resulting in an approved supplemental request for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxen (Naproxen)
  • Naproxen sodium (naproxen sodium)

Snippet

SUPPL AP for NAPROXEN (NAPROXEN SODIUM)